Ryan G. Lim

ORCID: 0000-0001-6388-5158
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genetic Neurodegenerative Diseases
  • Mitochondrial Function and Pathology
  • Amyotrophic Lateral Sclerosis Research
  • RNA Research and Splicing
  • Pluripotent Stem Cells Research
  • Neurogenetic and Muscular Disorders Research
  • Ubiquitin and proteasome pathways
  • Genomics and Phylogenetic Studies
  • Epigenetics and DNA Methylation
  • Mesenchymal stem cell research
  • Autophagy in Disease and Therapy
  • Collagen: Extraction and Characterization
  • 3D Printing in Biomedical Research
  • Electrospun Nanofibers in Biomedical Applications
  • Silk-based biomaterials and applications
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Antibiotic Resistance in Bacteria
  • Muscle Physiology and Disorders
  • Bacterial Identification and Susceptibility Testing
  • Tissue Engineering and Regenerative Medicine
  • Molecular Biology Techniques and Applications
  • Cancer-related molecular mechanisms research
  • Clinical Reasoning and Diagnostic Skills
  • Radiology practices and education
  • Skin and Cellular Biology Research

University of California, Irvine
2016-2024

Chan Zuckerberg Initiative (United States)
2024

Nova Southeastern University
2024

University of California, San Francisco
2024

McMaster University
2024

Berkeley College
2024

University of California, Berkeley
2024

Agency for Science, Technology and Research
2021-2024

Bioprocessing Technology Institute
2024

Cedars-Sinai Medical Center
2024

Brain microvascular endothelial cells (BMECs) are an essential component of the blood-brain barrier (BBB) that shields brain against toxins and immune cells. While BBB dysfunction exists in neurological disorders, including Huntington's disease (HD), it is not known if BMECs themselves functionally compromised to promote dysfunction. Further, underlying mechanisms remain elusive given limitations with mouse models post-mortem tissue identify primary deficits. We undertook a transcriptome...

10.1016/j.celrep.2017.04.021 article EN cc-by-nc-nd Cell Reports 2017-05-01
Emily G. Baxi Terri G. Thompson Jonathan Li Julia Kaye Ryan G. Lim and 95 more Jie Wu Divya Ramamoorthy Leandro de Araújo Lima Vineet Vaibhav Andrea Matlock Aaron P. Frank Alyssa N. Coyne Barry Landin Loren Ornelas Elizabeth Mosmiller Sara Thrower S. Michelle Farr Lindsey Panther Emilda Gomez Erick Galvez Daniel I. Pérez Imara Meepe Susan Lei Berhan Mandefro Hannah Trost Louis Pinedo Maria G. Bañuelos Chunyan Liu Ruby Moran Veronica J. Garcia Michael J. Workman Ritchie Ho Stacia K. Wyman Jennifer Roggenbuck Matthew B. Harms Jennifer Stocksdale Ricardo Miramontes Keona Wang Vidya Venkatraman Ronald Holewenski Niveda Sundararaman Rakhi Pandey Danica-Mae Manalo Aneesh Donde Nhan Huynh Miriam Adam Brook T. Wassie Edward Vertudes Naufa Amirani Krishna Raja Reuben Thomas Lindsey R. Hayes Alex Lenail Aianna Cerezo Sarah Luppino Alanna Farrar Lindsay Pothier Carolyn Prina Todd E. Morgan Arish Jamil Sarah Heintzman Jennifer Jockel‐Balsarotti Elizabeth Karanja Jesse Markway Molly McCallum Ben Joslin Deniz Alibazoglu Stephen J. Kolb Senda Ajroud‐Driss Robert H. Baloh Daragh Heitzman T. W. Miller Jonathan D. Glass Natasha Leanna Patel-Murray Hong Yu Ervin Sinani Prasha Vigneswaran Alexander Sherman Omar Ahmad Promit Roy Jay Beavers Steven R. Zeiler John W. Krakauer Carla Agurto Guillermo Cecchi Mary Bellard Yogindra Raghav Karen Sachs Tobias Ehrenberger Elizabeth Bruce Merit Cudkowicz Nicholas J. Maragakis Raquel Norel Jennifer E. Van Eyk Steven Finkbeiner James Berry Dhruv Sareen Leslie M. Thompson Ernest Fraenkel Clive N. Svendsen

Answer ALS is a biological and clinical resource of patient-derived, induced pluripotent stem (iPS) cell lines, multi-omic data derived from iPS neurons longitudinal smartphone over 1,000 patients with ALS. This provides population-level that may be employed to identify clinical-molecular-biochemical subtypes amyotrophic lateral sclerosis (ALS). A unique smartphone-based system was collect deep data, including fine motor activity, speech, breathing linguistics/cognition. The spinal were...

10.1038/s41593-021-01006-0 article EN cc-by Nature Neuroscience 2022-02-01

Using induced pluripotent stem cells (iPSCs) to understand the mechanisms of neurological disease holds great promise; however, there is a lack well-curated lines from large array participants. Answer ALS has generated over 1,000 iPSC control and amyotrophic lateral sclerosis (ALS) patients along with clinical whole-genome sequencing data. The current report summarizes cell marker gene expression in motor neuron cultures derived 92 healthy 341 participants using 32-day differentiation...

10.1016/j.neuron.2023.01.010 article EN cc-by-nc-nd Neuron 2023-02-09

Chronic cellular stress associated with neurodegenerative disease can result in the persistence of granule (SG) structures, membraneless organelles that form response to stress. In Huntington's (HD), chronic expression mutant huntingtin generates various forms stress, including activation unfolded protein and oxidative However, it has yet be determined whether SGs are a feature HD neuropathology. We examined miRNA composition extracellular vesicles (EVs) present cerebrospinal fluid (CSF)...

10.1172/jci140723 article EN Journal of Clinical Investigation 2021-05-04

ABSTRACT Metagenomics has enabled the rapid, unbiased detection of microbes across diverse sample types, leading to exciting discoveries in infectious disease, microbiome, and viral research. However, analysis metagenomic data is often complex computationally resource-intensive. CZ ID a free, cloud-based genomic platform that enables researchers detect using data, identify antimicrobial resistance genes, generate consensus genomes. With ID, can upload raw sequencing find matches NCBI...

10.1101/2024.02.29.579666 preprint EN cc-by bioRxiv (Cold Spring Harbor Laboratory) 2024-03-02

Creating a cDNA library for deep mRNA sequencing (mRNAseq) is generally done by random priming, creating multiple fragments along each transcript. A 3'-end-focused approach cannot detect differential splicing, but has potentially higher throughput at lower cost, with the ability to improve quantification using transcript molecule counting unique molecular identifiers (UMI) that correct PCR bias. Here, we compare an implementation of such 3'-digital gene expression (3'-DGE) "conventional"...

10.1038/s41598-017-14892-x article EN cc-by Scientific Reports 2017-11-01

Aberrant neuronal development and the persistence of mitotic cellular populations have been implicated in a multitude neurological disorders, including Huntington's disease (HD). However, mechanism underlying this potential pathology remains unclear. We used modified protocol to differentiate induced pluripotent stem cells (iPSCs) from HD patients unaffected controls into cultures enriched for medium spiny neurons, cell type most affected HD. performed single-cell bulk transcriptomic...

10.1016/j.stemcr.2020.01.015 article EN cc-by-nc-nd Stem Cell Reports 2020-02-27

DNA damage repair genes are modifiers of disease onset in Huntington's (HD), but how this process intersects with associated pathways remains unclear. Here we evaluated the mechanistic contributions protein inhibitor activated STAT-1 (PIAS1) HD mice and patient-derived induced pluripotent stem cells (iPSCs) find a link between PIAS1 pathways. We show that is component transcription-coupled complex, includes end processing enzyme polynucleotide kinase-phosphatase (PNKP), SUMO E3 ligase for...

10.1073/pnas.2021836118 article EN cc-by-nc-nd Proceedings of the National Academy of Sciences 2021-01-18

Abstract The complexity of affected brain regions and cell types is a challenge for Huntington’s disease (HD) treatment. Here we use single nucleus RNA sequencing to investigate molecular pathology in the cortex striatum from R6/2 mice human HD post-mortem tissue. We identify type-specific -agnostic signatures suggesting oligodendrocytes (OLs) oligodendrocyte precursors (OPCs) are arrested intermediate maturation states. OL-lineage regulators OLIG1 OLIG2 negatively correlated with CAG length...

10.1038/s41467-022-35388-x article EN cc-by Nature Communications 2022-12-21
Divya Ramamoorthy Kristen Severson Soumya Ghosh Karen Sachs Emily G. Baxi and 95 more Alyssa N. Coyne Elizabeth Mosmiller Lindsey R. Hayes Aianna Cerezo Omar Ahmad Promit Roy Steven R. Zeiler John W. Krakauer Jonathan Li Aneesh Donde Nhan Huynh Miriam Adam Brook T. Wassie Alex Lenail Natasha Leanna Patel-Murray Yogindra Raghav Karen Sachs Velina Kozareva Stanislav Tsitkov Tobias Ehrenberger Julia Kaye Leandro de Araújo Lima Stacia K. Wyman Edward Vertudes Naufa Amirani Krishna Kumar Raja Reuben Thomas Ryan G. Lim Ricardo Miramontes Jie Wu Vineet Vaibhav Andrea Matlock Vidya Venkatraman Ronald Holewenski Niveda Sundararaman Rakhi Pandey Danica-Mae Manalo Aaron P. Frank Loren Ornelas Lindsey Panther Emilda Gomez Erick Galvez Daniel I. Pérez Imara Meepe Susan Lei Louis Pinedo Chunyan Liu Ruby Moran Dhruv Sareen Barry Landin Carla Agurto Guillermo Cecchi Raquel Norel Sara Thrower Sarah Luppino Alanna Farrar Lindsay Pothier Hong Yu Ervin Sinani Prasha Vigneswaran Alexander Sherman S. Michelle Farr Berhan Mandefro Hannah Trost Maria G. Bañuelos Verónica Vázquez García Michael Workman Ritchie Ho Robert H. Baloh Jennifer Roggenbuck Matthew B. Harms Carolyn Prina Sarah Heintzman Stephen J. Kolb Jennifer Stocksdale Keona Wang Todd M. Morgan Daragh Heitzman Arish Jamil Jennifer Jockel‐Balsarotti Elizabeth Karanja Jesse Markway Molly McCallum Timothy J. Miller Ben Joslin Deniz Alibazoglu Senda Ajroud‐Driss Jay C. Beavers Mary Bellard Elizabeth J. Bruce Nicholas J. Maragakis Merit Cudkowicz James Berry Terri G. Thompson Steven Finkbeiner

Abstract The clinical presentation of amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease, varies widely across patients, making it challenging to determine if potential therapeutics slow progression. We sought whether there were common patterns disease progression that could aid in the design and analysis trials. developed an approach based on mixture Gaussian processes identify clusters patients sharing similar patterns, modeling their average trajectories variability...

10.1038/s43588-022-00299-w article EN cc-by Nature Computational Science 2022-09-08

Altered cellular metabolism is believed to be an important contributor pathogenesis of the neurodegenerative disorder Huntington's disease (HD). Research has primarily focused on mitochondrial toxicity, which can cause death vulnerable striatal neurons, but other aspects have also been implicated. Most previous studies carried out using postmortem human brain or non-human cells. Here, we studied bioenergetics in induced pluripotent stem cell-based model disease. We found decreased adenosine...

10.1093/hmg/ddy430 article EN cc-by-nc Human Molecular Genetics 2019-02-15
Jonathan Li Ryan G. Lim Julia Kaye Victoria Dardov Alyssa N. Coyne and 95 more Jie Wu Pamela Milani Andrew T. Cheng Terri G. Thompson Loren Ornelas Aaron P. Frank Miriam Adam Maria G. Bañuelos Malcolm Casale Veerle Cox Renan Escalante-Chong J. Gavin Daigle Emilda Gomez Lindsey R. Hayes Ronald Holewenski Susan Lei Alex Lenail Leandro de Araújo Lima Berhan Mandefro Andrea Matlock Lindsay Panther Natasha Leanna Patel-Murray Jacqueline T. Pham Divya Ramamoorthy Karen Sachs Brandon Shelley Jennifer Stocksdale Hannah Trost Mark Wilhelm Vidya Venkatraman Brook T. Wassie Stacia K. Wyman Stephanie Yang Jennifer E. Van Eyk Thomas E. Lloyd Steven Finkbeiner Ernest Fraenkel Jeffrey D. Rothstein Dhruv Sareen Clive N. Svendsen Leslie M. Thompson Hemali Phatnani Justin Kwan Dhruv Sareen James R. Broach Zachary Simmons Ximena Arcila-Londono Edward B. Lee Vivianna M Van Deerlin Neil A. Shneider Ernest Fraenkel Lyle W. Ostrow Frank Baas Noah Zaitlen James Berry Andrea Malaspina Pietro Fratta Gregory A. Cox Leslie M. Thompson Steven Finkbeiner Efthimios Dardiotis Timothy M. Miller Siddharthan Chandran Suvankar Pal Eran Hornstein Daniel J. MacGowan Terry Heiman‐Patterson Molly Hammell Nikolaos A. Patsopoulos Oleg Butovsky Josh Dubnau Avindra Nath Robert Bowser Matt Harms Mary Poss Jennifer E. Phillips‐Cremins John F. Crary Nazem Atassi Dale J. Lange Darius J. Adams Leonidas Stefanis Marc Gotkine Robert H. Baloh Suma Babu Towfique Raj Sabrina Paganoni Ophir Shalem Colin Smith Bin Zhang Brent T. Harris Iris Broce Vivian E. Drory John Ravits Corey T. McMillan Vilas Menon

Neurodegenerative diseases are challenging for systems biology because of the lack reliable animal models or patient samples at early disease stages. Induced pluripotent stem cells (iPSCs) could address these challenges. We investigated DNA, RNA, epigenetics, and proteins in iPSC-derived motor neurons from patients with ALS carrying hexanucleotide expansions

10.1016/j.isci.2021.103221 article EN cc-by iScience 2021-10-13
Stanislav Tsitkov Kelsey Valentine Velina Kozareva Aneesh Donde Aaron P. Frank and 95 more Susan Lei Michael J. Workman Ryan G. Lim Jie Wu Zhuoxing Wu Loren Ornelas Lindsay Panther Erick Galvez Daniel I. Pérez Imara Meepe Viviana Valencia Emilda Gomez Chunyan Liu Ruby Moran Louis Pinedo Ritchie Ho Julia Kaye Terri G. Thompson Dillon Shear Robert W. Baloh Maria G. Bañuelos Veronica J. Garcia Ronald Holewenski О Э Карпов Danica-Mae Manalo Berhan Mandefro Andrea Matlock Rakhi Pandey Niveda Sundararaman Hannah Trost Vineet Vaibhav Vidya Venkatraman Oliver Wang Jonathan D. Glass Arish Jamil Naufa Amirani Leandro de Araújo Lima Krishna Raja Wesley Robinson Reuben Thomas Edward Vertudes Stacia K. Wyman Carla Agurto Guillermo Cecchi Raquel Norel Omar Ahmad Emily G. Baxi Aianna Cerezo Alyssa N. Coyne Lindsey R. Hayes John W. Krakauer Nicholas J. Maragakis Elizabeth Mosmiller Promit Roy Steven R. Zeiler Miriam Adam Noura Albistami Tobias Ehrenberger Nhan Huynh Connie New Alex Lenail Jonathan Li Natasha Leanna Patel-Murray Yogindra Raghav Divya Ramamoorthy Egun Im Karen Sachs Brook T. Wassie James Berry Merit Cudkowicz Alanna Farrar Sara Thrower Sarah Luppino Lindsay Pothier Alexander Sherman Ervin Sinani Prasha Vigneswaran Hong Yu Jay C. Beavers Mary Bellard Elizabeth Bruce Senda Ajroud‐Driss Deniz Alibazoglu Ben Joslin Matthew B. Harms Sarah Heintzman Stephen J. Kolb Carolyn Prina Daragh Heitzman Todd E. Morgan Ricardo Miramontes Jennifer Stocksdale Keona Wang Jennifer Jockel‐Balsarotti Elizabeth Karanja

Amyotrophic Lateral Sclerosis (ALS), like many other neurodegenerative diseases, is highly heritable, but with only a small fraction of cases explained by monogenic disease alleles. To better understand sporadic ALS, we report epigenomic profiles, as measured ATAC-seq, motor neuron cultures derived from diverse group 380 ALS patients and 80 healthy controls. We find that chromatin accessibility heavily influenced sex, the iPSC cell type origin, ancestry, inherent variance arising sequencing....

10.1038/s41467-024-47758-8 article EN cc-by Nature Communications 2024-05-02

Understanding the normal function of Huntingtin (HTT) protein is significance in design and implementation therapeutic strategies for Huntington’s disease (HD). Expansion CAG repeat HTT gene, encoding an expanded polyglutamine (polyQ) within protein, causes HD may compromise HTT’s activity contributing to pathology. Here, we investigated previously defined role autophagy specifically through studying association with ubiquitin. We find that interacts directly ubiquitin vitro. Tandem affinity...

10.1073/pnas.2319091121 article EN cc-by Proceedings of the National Academy of Sciences 2024-07-29

Significance Huntington’s disease (HD) is a devastating neurodegenerative disorder caused by expansion of polyglutamine repeat within the huntingtin (HTT) protein. A normal function HTT that scaffold for selective autophagy, mechanism protein and organelle degradation lysosome required neuronal health. Here, we show inflammatory IκB kinase (IKK) subunit IKKβ may in vivo to regulate autophagy through direct phosphorylation at serine 13 activation gene expression. slow HD behavioral...

10.1073/pnas.1814246116 article EN cc-by-nc-nd Proceedings of the National Academy of Sciences 2019-05-14

Huntington disease (HD) is a neurodegenerative disorder caused by expanded CAG repeats in the huntingtin gene that alters cellular homeostasis, particularly striatum and cortex. Astrocyte signaling establishes maintains neuronal functions are often altered under pathological conditions. We performed single-nuclei RNA-sequencing on human HD patient-induced pluripotent stem cell (iPSC)-derived astrocytes striatal cortical tissue from R6/2 mice to investigate high-resolution astrocyte state...

10.1016/j.isci.2022.105732 article EN cc-by iScience 2022-12-06

The National Institute of Health (NIH) Library integrated network-based cellular signatures (LINCS) program is premised on the generation a publicly available data resource cell-based biochemical responses or "signatures" to genetic environmental perturbations. NeuroLINCS uses human inducible pluripotent stem cells (hiPSCs), derived from patients and healthy controls, differentiated into motor neuron cell cultures. This multi-laboratory effort strives establish i) robust multi-omic workflows...

10.1038/s41597-022-01687-7 article EN cc-by Scientific Data 2023-01-11

Huntington's disease (HD), a genetic neurodegenerative disorder, primarily affects the striatum and cortex with progressive loss of medium-sized spiny neurons (MSNs) pyramidal neurons, disrupting cortico-striatal circuitry. A promising regenerative therapeutic strategy transplanting human neural stem cells (hNSCs) is challenged by need for long-term functional integration. We previously described that, short-term hNSC transplantation into HD R6/2 mice, differentiated electrophysiologically...

10.1016/j.ymthe.2023.10.003 article EN cc-by-nc-nd Molecular Therapy 2023-10-07
Coming Soon ...